570 Biowissenschaften; Biologie
Refine
Year of publication
Document Type
- Article (2093)
- Doctoral Thesis (737)
- Preprint (219)
- Part of Periodical (78)
- Book (16)
- Conference Proceeding (12)
- Part of a Book (10)
- Periodical (3)
- Report (2)
- Working Paper (2)
Language
- English (3174) (remove)
Is part of the Bibliography
- no (3174)
Keywords
- RNA (20)
- aging (20)
- SARS-CoV-2 (19)
- inflammation (18)
- taxonomy (17)
- Biochemistry (16)
- Podospora anserina (16)
- mitochondria (16)
- Cell biology (15)
- NMR (15)
Institute
- Biowissenschaften (1220)
- Biochemie und Chemie (550)
- Medizin (454)
- Biochemie, Chemie und Pharmazie (346)
- Institut für Ökologie, Evolution und Diversität (176)
- Senckenbergische Naturforschende Gesellschaft (160)
- Biodiversität und Klima Forschungszentrum (BiK-F) (123)
- Exzellenzcluster Makromolekulare Komplexe (116)
- MPI für Biophysik (104)
- Frankfurt Institute for Advanced Studies (FIAS) (94)
Herman P. Schwan [1915–2005] was a distinguished scientist and engineer, and a founding father of the field of biomedical engineering. A man of integrity, Schwan influenced the lives of many, including his wife and children, and his many students and colleagues. Active in science until nearly the end of his life, he will be very much missed by his family and many colleagues.
High-throughput gene trapping is a random approach for inducing insertional mutations across the mouse genome. This approach uses gene trap vectors that simultaneously inactivate and report the expression of the trapped gene at the insertion site, and provide a DNA tag for the rapid identification of the disrupted gene. Gene trapping has been used by both public and private institutions to produce libraries of embryonic stem (ES) cells harboring mutations in single genes. Presently,~ 66% of the protein coding genes in the mouse genome have been disrupted by gene trap insertions. Among these, however, genes encoding signal peptides or transmembrane domains (secretory genes) are underrepresented because they are not susceptible to conventional trapping methods. Here, we describe a high-throughput gene trapping strategy that effectively targets secretory genes. We used this strategy to assemble a library of ES cells harboring mutations in 716 unique secretory genes, of which 61% were not trapped by conventional trapping, indicating that the two strategies are complementary. The trapped ES cell lines, which can be ordered from the International Gene Trap Consortium (http://www.genetrap.org), are freely available to the scientific community.
Background: Cancer gene therapy will benefit from vectors that are able to replicate in tumor tissue and cause a bystander effect. Replication-competent murine leukemia virus (MLV) has been described to have potential as cancer therapeutics, however, MLV infection does not cause a cytopathic effect in the infected cell and viral replication can only be studied by immunostaining or measurement of reverse transcriptase activity. Results: We inserted the coding sequences for green fluorescent protein (GFP) into the proline-rich region (PRR) of the ecotropic envelope protein (Env) and were able to fluorescently label MLV. This allowed us to directly monitor viral replication and attachment to target cells by flow cytometry. We used this method to study viral replication of recombinant MLVs and split viral genomes, which were generated by replacement of the MLV env gene with the red fluorescent protein (RFP) and separately cloning GFP-Env into a retroviral vector. Co-transfection of both plasmids into target cells resulted in the generation of semi-replicative vectors, and the two color labeling allowed to determine the distribution of the individual genomes in the target cells and was indicative for the occurrence of recombination events. Conclusions: Fluorescently labeled MLVs are excellent tools for the study of factors that influence viral replication and can be used to optimize MLV-based replication-competent viruses or vectors for gene therapy.
We have isolated the human protein SNEV as downregulated in replicatively senescent cells. Sequence homology to the yeast splicing factor Prp19 suggested that SNEV might be the orthologue of Prp19 and therefore might also be involved in pre-mRNA splicing. We have used various approaches including gene complementation studies in yeast using a temperature sensitive mutant with a pleiotropic phenotype and SNEV immunodepletion from human HeLa nuclear extracts to determine its function. A human–yeast chimera was indeed capable of restoring the wild-type phenotype of the yeast mutant strain. In addition, immunodepletion of SNEV from human nuclear extracts resulted in a decrease of in vitro pre-mRNA splicing efficiency. Furthermore, as part of our analysis of protein–protein interactions within the CDC5L complex, we found that SNEV interacts with itself. The self-interaction domain was mapped to amino acids 56–74 in the protein's sequence and synthetic peptides derived from this region inhibit in vitro splicing by surprisingly interfering with spliceosome formation and stability. These results indicate that SNEV is the human orthologue of yeast PRP19, functions in splicing and that homo-oligomerization of SNEV in HeLa nuclear extract is essential for spliceosome assembly and that it might also be important for spliceosome stability.
In order to further understand how DNA polymerases discriminate against incorrect dNTPs, we synthesized two sets of dNTP analogues and tested them as substrates for DNA polymerase a (pol alpha) and Klenow fragment (exo-) of DNA polymerase I (Escherichia coli ). One set of analogues was designed to test the importance of the electronic nature of the base. The bases consisted of a benzimidazole ring with one or two exocyclic substituent(s) that are either electron-donating (methyl and methoxy) or electronwithdrawing (trifluoromethyl and dinitro). Both pol a and Klenow fragment exhibit a remarkable inability to discriminate against these analogues as compared to their ability to discriminate against incorrect natural dNTPs. Neither polymerase shows any distinct electronic or steric preferences for analogue incorporation. The other set of analogues, designed to examine the importance of hydrophobicity in dNTP incorporation, consists of a set of four regioisomers of trifluoromethyl benzimidazole. Whereas pol a and Klenow fragment exhibited minimal discrimination against the 5- and 6-regioisomers, they discriminated much more effectively against the 4- and 7-regioisomers. Since all four of these analogues will have similar hydrophobicity and stacking ability, these data indicate that hydrophobicity and stacking ability alone cannot account for the inability of pol a and Klenow fragment to discriminate against unnatural bases. After incorporation, however, both sets of analogues were not efficiently elongated. These results suggest that factors other than hydrophobicity, sterics and electronics govern the incorporation of dNTPs into DNA by pol {alpha} and Klenow fragment.
Lesion of the rat entorhinal cortex denervates the outer molecular layer of the fascia dentata followed by layer-specific axonal sprouting of uninjured fibers in the denervated zone. One of the candidate molecules regulating the laminar-specific sprouting response in the outer molecular layer is the transmembrane chondroitin sulfate proteoglycan NG2. NG2 is found in glial scars and has been suggested to impede axonal regeneration following injury of the spinal cord. The present study adressed the question whether NG2 could also regulate axonal growth in denervated areas of the brain. Therefore, (1) changes in NG2 mRNA and NG2 protein levels, (2) the cellular and the extracellular localisation of the molecule, (3) the identity of NG2 expressing cells, and (4) the generation of NG2-positive cells were studied in the rat fascia dentata before and following entorhinal deafferentation. Laser microdissection was employed to selectively harvest the denervated molecular layer and combined with quantitative reverse transcription-PCR to measure changes in NG2 mRNA amount (6h, 12h, 2d, 4d, 7d post lesion). The study revealed increases of NG2 mRNA at day 2 (2.5-fold) and day 4 (2-fold) post lesion. Immunocytochemistry was used to detect changes in NG2 protein distribution (1d, 4d, 7d, 10d, 14d, 30d, 6 months post lesion). NG2 staining was increased in the denervated outer molecular layer at 1 day post lesion, reached a maximum at 10 days post lesion, and returned to control levels within 6 month. Interestingly, the accumulation of NG2 protein was strongly restricted to the denervated outer molecular layer forming a border to the unaffected inner molecular layer. Using electron microscopy, NG2-immunoprecipitate was localized not only on glial surfaces and in the extracellular matrix but also in the vicinity of neuronal profiles indicating that NG2 is secreted following denervation. Double-labelings of NG2-immunopositive cells with markers for astrocytes, microglia/macrophages, and oligodendrocytes suggested that NG2-cells are a distinct glial subpopulation before and after entorhinal deafferentation. Bromodeoxyuridine-labeling revealed that some of the NG2-positive cells are postlesional generated. Taken together, the data revealed a layer-specific upregulation of NG2 in the denervated outer molecular layer of the fascia dentata that coincides with the sprouting response of uninjured fibers. This suggests that NG2 could regulate lesion-induced axonal growth in denervated areas of the brain.
Mitochondial NADH:ubiquinone oxidoreductase (complex I) the largest multiprotein enzyme of the respiratory chain, catalyses the transfer of two electrons from NADH to ubiquinone, coupled to the translocation of four protons across the membrane. In addition to the 14 strictly conserved central subunits it contains a variable number of accessory subunits. At present, the best characterized enzyme is complex I from bovine heart with a molecular mass of about 980 kDa and 32 accessory proteins. In this study, the subunit composition of mitochondrial complex I from the aerobic yeast Y. lipolytica has been analysed by a combination of proteomic and genomic approaches. The sequences of 37 complex I subunits were identified. The sum of their individual molecular masses (about 930 kDa) was consistent with the native molecular weight of approximately 900 kDa for Y. lipolytica complex I obtained by BN-PAGE. A genomic analysis with Y. lipolytica and other eukaryotic databases to search for homologues of complex I subunits revealed 31 conserved proteins among the examined species. A novel protein named “X” was found in purified Y. lipolytica complex I by MALDI-MS. This protein exhibits homology to the thiosulfate sulfurtransferase enzyme referred to as rhodanese. The finding of a rhodanese-like protein in isolated complex I of Y. lipolytica allows to assume a special regulatory mechanism of complex I activity through control of the status of its iron-sulfur clusters. The second part of this study was aimed at investigating the possible role of one of these extra subunits, 39 kDa (NUEM) subunit which is related to the SDRs-enzyme family. The members of this family function in different redox and isomerization reactions and contain a conserved NAD(P)H-binding site. It was proposed that the 39 kDa subunit may be involved in a biosynthetic pathway, but the role of this subunit in complex I is unknown. In contrast to the situation in N. crassa, deletion of the 39 kDa encoding gene in Y. lipolytica led to the absence of fully assembled complex I. This result might indicate a different pathway of complex I assembly in both organisms. Several site-directed mutations were generated in the nucleotide binding motif. These had either no effect on enzyme activity and NADPH binding, or prevented complex I assembly. Mutations of arginine-65 that is located at the end of the second b-strand and responsible for selective interaction with the 2’-phosphate group of NADPH retained complex I activity in mitochondrial membranes but the affinity for the cofactor was markedly decreased. Purification of complex I from mutants resulted in decrease or loss of ubiquinone reductase activity. It is very likely that replacement of R65 not only led to a decrease in affinity for NADPH but also caused instability of the enzyme due to steric changes in the 39 kDa subunit. These data indicate that NADPH bound to the 39 kDa subunit (NUEM) is not essential for complex I activity, but probably involved in complex I assembly in Y. lipolytica.
The thesis entitled „Investigations on the significance of nucleo-cytoplasmic transport for the biological function of cellular proteins" aimed to unreveal molecular mechanisms in order to improve our understanding of the impact of nucleo-cytoplasmic transport on cellular functions. Within the scope of this work, it could be shown that regulated nucleo-cytoplasmic transport of a subfamily of homeobox transcription factors controlled their intra- and intercellular transport, and thereby influencing also their transcriptional activity. This study describes a novel regulatory mechanism, which could in general play an important role for the ordered differentiation of complex organisms. Besides cis-active transport Signals, also post-translational modifications can influence the localization and biological activity of proteins in trans. In addition to the known impact of phosphorylation on the transport and activity of STAT1, experimental evidence was provided demonstrating that acetylation affected the interaction of STAT1 with NF-kB p65, and subsequently modulated the expression of apoptosis-inducing NF-kB target genes. The impact of nucleo-cytoplasmic transport on the regulation of apoptosis was underlined by showing that the evolutionary conservation of a NES within the anti-apoptotic protein survivin plays an essential role for its dual function in the inhibition of apoptosis and ordered cell division. Since survivin is considered a bona fide cancer therapy target, these results strongly encourage future work to identify molecular decoys that specifically inhibit the nuclear export of survivin as novel therapeutics. In order to further dissect the regulation of nuclear transport and to efficiently identify transport inhibitors, cell-based assays are urgently required. Therefore, the cellular assay Systems developed in this work may not only serve to identify synthetic nuclear export and Import inhibitors but may also be applied in systematic RNAi-screening approaches to identify novel components of the transport machinery. In addition, the translocation based protease- and protein-interaction biosensors can be applied in various biological Systems, in particular to identify protein-protein interaction inhibitors of cancer relevant proteins. In summary, this work does not only underline the general significance of nucleo-cytoplasmic transport for cell biology, but also demonstrates its potential for the development of novel therapies against diseases like cancer and viral infections.
Calcium-activated potassium channels are fundamental regulators of neuron excitability. SK channels are activated by an intracellular increase of Ca++ (such as occurs during an action potential). They have a small single channel conductance (less than 20pS) and show no voltage dependence of activation. To date, there are only a few examples of high-resolution structures of eukaryotic membrane proteins. All of them were purified from natural sources. Since no abundant natural sources of eukaryotic K+ channels are available we overexpressed rSK2 in order to produce the quantities necessary for structural analysis. Unfortunately the Pichia pastoris expression system did not yield sufficient amount of pure protein, mainly because most of the protein was retained by in the ER and was only partially soluble. Subsequently, two constructs were expressed: SK2-FCYENE (containing a specific sequence that promotes surface expression), and SK2-q-CaM a concatamer of SK2 and calmodulin. Although these proved an improvement in terms of solubilisation, little improvement was found in terms of amounts of purified material obtained. For this reason we tested the Semliki Forest virus expression system, since the protein is expressed in a mammalian system where we hoped that it would be trafficked in the same way as in vivo. Using this system it was possible to express rSK2 and solubilise it with several detergents and to achieve much better purification. However, the levels were still not sufficient for high-resolution structural studies, although sufficient for single particle electron microscopy analysis.
DCD – a novel plant specific domain in proteins involved in development and programmed cell death
(2005)
Background: Recognition of microbial pathogens by plants triggers the hypersensitive reaction, a common form of programmed cell death in plants. These dying cells generate signals that activate the plant immune system and alarm the neighboring cells as well as the whole plant to activate defense responses to limit the spread of the pathogen. The molecular mechanisms behind the hypersensitive reaction are largely unknown except for the recognition process of pathogens. We delineate the NRP-gene in soybean, which is specifically induced during this programmed cell death and contains a novel protein domain, which is commonly found in different plant proteins.
Results: The sequence analysis of the protein, encoded by the NRP-gene from soybean, led to the identification of a novel domain, which we named DCD, because it is found in plant proteins involved in d evelopment and c ell d eath. The domain is shared by several proteins in the Arabidopsis and the rice genomes, which otherwise show a different protein architecture. Biological studies indicate a role of these proteins in phytohormone response, embryo development and programmed cell by pathogens or ozone.
Conclusion: It is tempting to speculate, that the DCD domain mediates signaling in plant development and programmed cell death and could thus be used to identify interacting proteins to gain further molecular insights into these processes.
Prion diseases, also called transmissible spongiform encephalopathies, are a group of fatal neurodegenerative conditions that affect humans and a wide variety of animals. To date there is no therapeutic or prophylactic approach against prion diseases available. The causative infectious agent is the prion, also termed PrPSc, which is a pathological conformer of a cellular protein named prion protein PrPc. Prions are thought to multiply upon conversion of PrPc to PrPSc in a self-propagating manner. Immunotherapeutic strategies directed against PrPc represent a possible approach in preventing or curing prion diseases. Accordingly, it was already shown in animal models, that passive immunization delays the onset of prion diseases. The present thesis aimed at the development of a candidate vaccine towards the active immunization against prion diseases, an immune response, which has to be accompanied by the circumvention of host tolerance to the self-antigen PrPc. The vaccine development was approached using virus-like particles (retroparticles) derived from either the murine leukemia (MLV) or the human immunodeficiency virus (HIV). The display of PrP on the surface of such particles was addressed for both the cellular and the pathogenic form of PrP. The display of PrPc was achieved by either fusion to the transmembrane domain of the platelet derived growth factor receptor (PDGFR) or to the N-terminal part of the viral envelope protein (Env). In both cases, the corresponding PrPD- and PrPE-retroparticles were successfully produced and analyzed via immune fluorescence, Western Blot analysis, immunogold electron microscopy as well as by ELISA methods. Both, PrPD- and PrPE-retroparticles showed effective incorporation of N-terminally truncated forms of PrPc but not for the complete protein. PrPc at this revealed the typical glycosylation pattern, which was specifically removed by a glycosidase enzyme. Upon display of PrPc on retroparticles the protein remained detectable by PrP-specific antibodies under native conditions. Electron microscopy analysis of PrPc-variants revealed no alteration of the characteristic retroviral morphology of the generated particles. MLV-derived PrPD-retroparticles were successfully used in immunization studies. Contrary to approaches using bacterially expressed PrPc, the immunization of mice resulted in a specific antibody response. The display of the pathogenic isoform was aimed by two different strategies. The first one was directed at the conversion of the proteinase K (PK) sensitive from of PrP on the surface of PrPD-retroparticles into the PK resistant form. Albeit specific adaption of the PK digestion assay detecting resistant PrP, no PrP conversion was observed for PrPD-retroparticles. The second approach utilized a replication competent variant of the ecotropic MLV displaying PrPc on the viral Env protein. This MLV variant was stable in cell culture for six passages but did not replicate on scrapie-infected, PrPSc-propagating neuroblastoma cells. Thus, besides PrPc-displaying virus-like particles a replication competent MLV variant was obtained, which stably incorporated PrPc at the N-terminus of the viral Env protein. The incorporation of the cell-surface located PrPc into particles was expected from previously obtained data on protein display in the context of retrovirus-derived particles. Thus, the lack of incorporation observed for the complete PrPc sequence was rather unexpected and was found to be inhibited at both, fusion to PDGFR and the viral Env. In contrast to N-terminally truncated PrPc, the complete PrPc was shown to exhibit increased cell surface internalization rates and half-life times eventually contributing to the observed results. The PrP-vaccination approach described in this work represents the first successful system inducing PrP-specific antibody responses against the prion protein in wt mice. Explanations at this are based on the induction of specific T cell help or effects of the innate immunity, respectively. MLV-and HIV-derived particles bearing the PrP-coding sequence or being replication competent variants generated during this thesis might help to further improve the PrP-specific immune response.
Background: In rat, deafferentation of one labyrinth (unilateral labyrinthectomy) results in a characteristic syndrome of ocular and motor postural disorders (e.g., barrel rotation, circling behavior, and spontaneous nystagmus). Behavioral recovery (e.g., diminished symptoms), encompassing 1 week after unilateral labyrinthectomy, has been termed vestibular compensation. Evidence suggesting that the histamine H3 receptor plays a key role in vestibular compensation comes from studies indicating that betahistine, a histamine-like drug that acts as both a partial histamine H1 receptor agonist and an H3 receptor antagonist, can accelerate the process of vestibular compensation. Results: Expression levels for histamine H3 receptor (total) as well as three isoforms which display variable lengths of the third intracellular loop of the receptor were analyzed using in situ hybridization on brain sections containing the rat medial vestibular nucleus after unilateral labyrinthectomy. We compared these expression levels to H3 receptor binding densities. Total H3 receptor mRNA levels (detected by oligo probe H3X) as well as mRNA levels of the three receptor isoforms studied (detected by oligo probes H3A, H3B, and H3C) showed a pattern of increase, which was bilaterally significant at 24 h post-lesion for both H3X and H3C, followed by significant bilateral decreases in medial vestibular nuclei occurring 48 h (H3X and H3B) and 1 week post-lesion (H3A, H3B, and H3C). Expression levels of H3B was an exception to the forementioned pattern with significant decreases already detected at 24 h post-lesion. Coinciding with the decreasing trends in H3 receptor mRNA levels was an observed increase in H3 receptor binding densities occurring in the ipsilateral medial vestibular nuclei 48 h post-lesion. Conclusion: Progressive recovery of the resting discharge of the deafferentated medial vestibular nuclei neurons results in functional restoration of the static postural and occulomotor deficits, usually occurring within a time frame of 48 hours in rats. Our data suggests that the H3 receptor may be an essential part of pre-synaptic mechanisms required for reestablishing resting activities 48 h after unilateral labyrinthectomy.
In an attempt to search for potential candidate molecules involved in the pathogenesis of endometriosis, a novel 2910 bp cDNA encoding a putative 411 amino acid protein, shrew-1 was discovered. By computational analysis it was predicted to be an integral membrane protein with an outside-in transmembrane domain but no homology with any known protein or domain could be identified. Antibodies raised against the putative open-reading frame peptide of shrew-1 labelled a protein of ca. 48 kDa in extracts of shrew-1 mRNA positive tissues and also detected ectopically expressed shrew-1. In the course of my PhD work, I confirmed the prediction that shrew-1 is indeed a transmembrane protein, by expressing epitope-tagged shrew-1 in epithelial cells and analysing the transfected cells by surface biotinylation and immunoblots. Additionally, I could show that shrew-1 is able to target to E-cadherin-mediated adherens junctions and interacts with the E-cadherin-catenin complex in polarised MCF7 and MDCK cells, but not with the N-cadherin-catenin complex in non-polarised epithelial cells. A direct interaction of shrew-1 with beta-catenin could be shown in an in vitro pull-down assay. From this data, it could be assumed that shrew-1 might play a role in the function and/or regulation of the dynamics of E-cadherin-mediated junctional complexes. In the next part of my thesis, I showed that stable overexpression of shrew-1 in normal MDCK cells. causes changes in morphology of the cells and turns them invasive. Furthermore, transcription by ²-catenin was activated in these MDCK cells stably overexpressing shrew-1. It was probably the imbalance of shrew-1 protein at the adherens junctions that led to the misregulation of adherens junctions associated proteins, i.e. E-cadherin and beta-catenin. Caveolin-1 is another integral membrane protein that forms complexes with Ecadherin- beta-catenin complexes and also plays a role in the endocytosis of E-cadherin during junctional disruption. By immunofluorescence and biochemical studies, caveolin-1 was identified as another interacting partner of shrew-1. However, the functional relevance of this interaction is still not clear. In conclusion, it can be said that shrew-1 interacts with the key players of invasion and metastasis, E-cadherin and caveolin-1, suggesting its possible role in these processes and making it an interesting candidate to unravel other unknown mechanisms involved in the complex process of invasion.
Proton-translocating NADH:ubiquinone oxidoreductase (complex I) transports two electrons from NADH to membranal ubiquinone: in this process protons are translocated across the membrane, producing 40% of the total proton gradient between matrix side and intermembrane space. Mitochondrial complex I contains at least 46 subunits in mammals, and has a molecular weight of around 1000 kDa. Electronic microscopy analysis showed that complex I has an L-form, which consists of two domains: a peripheral “arm” (hydrophilic domain) and a membrane “arm” (hydrophobic domain). The peripheral domain, which protrudes into the matrix, contains one non-covalently bound flavin mononucleotide (FMN) and the iron-sulfur clusters N1a, N1b, N2, N3, N4 and N5 as redox active groups. They transport electrons from NADH to ubiquinone. Cluster N2 is supposed to be the immediate electron donor to ubiquinone by virtue of its highest and pH dependent redox midpoint potential (Em,7 –150 mV). The exact location of the tetra-nuclear cluster N2 is still object of discussion. The TYKY and the PSST subunits contain three binding motifs for tetranuclear clusters which are formed by twelve cysteins. In an effort to investigate the “ubiquinone reduction module” of complex I, in the first part of this work site directed mutagenesis of the TYKY and PSST subunits has been carried out. Mutant strains were characterised in terms of complex I content, catalytic activity and EPR signature of cluster N2. The second part of this work was aimed at developing a substrate inducible version of the internal alternative NADH:ubiquinone oxidoreductase (NDH2i). A substrate inducible NDH2i is expected to offer a “switch” between complex I activity dependent (no NDH2i activity) and independent (NDH2i activity) cell growth, by changing between activating and non-activating substrates. This strategy would allow the screening for two types of complex I mutants, which is a prerequisite for realising a random PCR mutagenesis of single subunits of complex I, that allows the production of a high number of point mutations in relatively short time. Y. lipolytica complex I deficiency mutant strains could be easily identified, by virtue of their inability to survive under complex I dependent growth conditions (no NDH2i activity). By this way, amino acids that have an important role for complex I structure or function could be identified by subsequent sequence analysis. Each of the twelve cysteines that form the above mentioned three binding motifs for iron-sulfur cluster have been mutagenised. In mutant mitochondrial membranes, no assembled complex I could be detected. From these data one may conclude that the mutagenised 6 SUMMARY 92 cysteines play an important role for complex I stability, or that are a prerequisite for complex I assembly in Y. lipolytica, but there is not direct evidence indicating that any of the four mutagenised residues acts as a ligand. Two aspartates in the PSST subunit, Asp-99 and Asp-115, were found to be essential for complex I catalytic activity. EPR spectroscopic analysis indicated that the electron transfer to N2 cluster was not blocked and implied that this was not the reason for the loss of catalytic activity. From these data it can be concluded that D99 and D115 play a vital role for complex I NADH:ubiquinone reductase activity, but are not ligands for cluster N2 and that their position is not close enough to the cluster to influence directly its electromagnetic environment. Three mutations, identified in the PSST and TYKY homologous subunits of patients affected with Leigh syndrome (V119M in PSST, P78L and R101H in TYKY) were reconstructed in the obligate aerobic yeast Y. lipolytica. This approach may help to understand the aetiology of the Leigh syndrome, in terms of the ability of complex I to oxidize NADH and to transport electrons. In fact, all three mutations showed effects on electron transport, reducing the VMax by about 50%. Mutant V119M in the PSST subunit, which had a lethal effect in two patients that were homozygous for this mutation, affects a fully conserved residue. Overall, the results from site directed mutagenesis carried out so far support the theory that the “catalytic core ” (N2 cluster and quinone binding site) of complex I has been evolved from the electron transfer module of the [Ni-Fe] hydrogenases. In fact, mutagenesis of residues that are fully conserved between complex I and [Ni-Fe] hydrogenases, showed dramatic effects on complex I in terms of assembly (cysteine mutants) or catalytic activity (D99-D115). Differently, changing aspartate 174 and glutamic acid 185 (not fully conserved, Fig 4.1A) had little or no effect on the Michaelis-Menten parameters and N2 EPR signal. In recent years Y. lipolytica has been developed as a yeast genetic system to study mitochondrial complex I. The present work introduced the promoter for the isocitrate lyase (pICL1) as a useful tool for the substrate selective expression of the internal version of the alternative NADH:ubiquinone oxidoreductase (pICL1-NDH2i). This allows to rescue complex I deficiencies “in vivo” selectively by growth on acetate (or ethanol) medium. The integration of the pICL1-NDH2i construct into the genome of Y. lipolytica and subsequent deletion of nuclear-coded subunits like PSST, TYKY and 49 kDa, would contribute to further develop this organism as a useful genetic model for studying subunits of mitochondrial complex I by site directed mutagenesis.
Ligands of Iron-Sulphur Cluster N2: In this work the ubiquinone reducing catalytic core of NADH:ubiquinone oxidoreductase (complex I) from Y. lipolytica was studied by a series of point mutations replacing conserved histidines or arginines in the 49-kDa subunit. Although the missing 4th ligand of cluster N2 could not be found in the 49-kDa subunit of complex I, it was clearly demonstrated that iron-sulphur cluster N2 resides directly on the interface between the PSST and 49-kDa subunits. The results presented in this work show that residues in the 49-kDa subunit have strong influence on this redox centre and also on catalytic activity. The strong influence of Arg-141 and His-226 residues in 49-kDa subunit on this cluster can be deducted from complete loss of N2 signals in EPR spectra such as in case of mutants H226A and R141A. In the case of mutant H226M the EPR signal from cluster N2 was shifted and cluster N2 even lost the pH dependence of its redox midpoint potential and became more similar to the other so called 'isopotential' clusters. Specifically in the case of mutants R141M and R141K the characteristic signature of cluster N2 became undetectable in EPR spectra. However, specific dNADH:DBQ oxidoreductase activity that could be inhibited with the specific complex I inhibitors DQA and rotenone was not absolutely abolished but rather reduced. These reductions in complex I activity did not correspond to similar reductions in the specific EPR signal of cluster N2 as it was observed in the His-226 mutant series. No indications could be found that these mutations had modified the magnetic properties of cluster N2, resulting in different EPR spectra. From these observations it could be concluded that both mutants R141K and R141M virtually or entirely lack iron-sulphur cluster N2. The rates in complex I activity could be reconciled with electron transfer theory: After removal of a single redox centre in a chain, electron transfer rates are predicted to be still much faster than steady-state turnover of complex I. These results from mutants R141K, R141M and also the result from mutant H226M that protons are being pumped even if the redox midpoint potential of cluster N2 is not pH dependent questions the prominent role in the catalytic mechanism of complex I that has been ascribed to cluster N2. Histidine 91 and 95 were found to be absolutely essential for activity of complex I since in both mutants complex I was fully assembled and artificial NADH:HAR activity was parental whereas complex I specific dNADH:DBQ activity was abolished. The signal from cluster N2 in EPR spectra was parental for all His-91 and -95 mutants. Mutations at the C-terminal arginine 466 affected ubiquinone affinity and inhibitor sensitivity but also destabilised complex I. All these results provide further support for a high degree of structural conservation between the 49-kDa subunit of complex I and the large subunit of water soluble [NiFe] hydrogenases. Remodelling of Human Pathogenic 49-kDa Mutations in Y. lipolytica: Y. lipolytica has been proven a good system for studying complex I properties and thus also for studying defects that occur in humans. In this work pathogenic mutations in the 49-kDa subunit of complex I were recreated and studied. The P232Q mutant showed non-assembly of complex I and this is probably the cause why this mutation was lethal in patients. The mutants R231Q and S416P were parental for the content, artificial and also specific complex I activity, Km for DBQ and IC50 for DQA. From these results we can conclude that these two residues Arg-228 and Ser-413 in mammalian cells have specific structural importance for the 49-kDa subunit even if they are not directly involved in catalytic process.
The endothelin B receptor belongs to the rhodopsin-like G-protein coupled receptors family. It plays an important role in vasodilatation and is found in the membranes of the endothelial cells enveloping blood vessels. During the course of this work, the production of recombinant human ETB receptor in yeast, insect and mammalian cells was evaluated. A number of different receptor constructs for production in the yeast P. pastoris was prepared. Various affinity tags were appended to the receptor N-and C-termini to enable receptor detection and purification. The clone pPIC9KFlagHisETBBio, with an expression level of 60 pmol/mg, yielded the highest amount of active receptor (1.2 mg of receptor per liter of shaking culture). The expression level of the same clone in fermentor culture was 17 pmol/mg, and from a 10L fermentor it was possible to obtain 3 kg of cells that contained 20-39 mg of the receptor. For receptor production in insect cells, Sf9 (S. frugiperda) suspension cells were infected with the recombinant baculovirus pVlMelFlagHisETBBio. The peak of receptor production was reached at 66 h post infection, and radioligand binding assays on insect cell membranes showed 30 pmoL of active receptor /mg of membrane protein. Subsequently, the efficiency of different detergents in solubilizing the active receptor was evaluated. N-dodecyl-beta-D-maltoside (LM), lauryl-sucrose and digitonine/cholate performed best, and LM was chosen for further work. The ETB receptor was produced in mammalian cells using the Semliki Forest Virus expression system. Radioligand binding assays on membranes from CHO cells infected with the recombinant virus pSFV3CAPETBHis showed 7 pmol of active receptor /mg of membrane protein. Since the receptor yield from mammalian cells was much lower than in yeast and insect cells, this system was not used for further large-scale receptor production. After production in yeast and insect cells, the ETB receptor was saturated with its ligand, endothelin-1, in order to stabilize its native form. The receptor was subsequently solubilized with n-dodecyl-beta-D-maltoside and subjected to purification on various affinity matrices. Two-step affinity purification via Ni2+-NTA and monomeric avidin proved the most efficient way to purify milligram amounts of the receptor. The purity of the receptor preparation after this procedure was over 95%, as judged from silver stained gels. However, the tendency of the ETB receptor produced in yeast to form aggregates was a constant problem. Attempts were made to stabilize the active, monomeric form of the receptor by testing a variety of different buffer conditions, but further efforts in this direction will be necessary in order to solve the aggregation problem. In contrast to preparations from yeast, the purification of the ETB receptor produced in insect cells yielded homogeneous receptor preparations, as shown by gel filtration analysis. This work has demonstrated that the amounts of receptor expressed in yeast and insect cells and the final yield of receptor, isolated by purification, represent a good basis for beginning 3D and continuing 2D crystallization trials.
Die Infrarotspektroskopie in Verbindung mit photoaktivierbaren Substraten wurde zur Untersuchung von Substrat-Protein-Wechselwirkungen eingesetzt. Dabei wurden Konformationsänderungen der Ca2+-ATPase des Sarkoplasmatischen Retikulums bei Bindung des Nukleotids, der Phosphorylierung der ATPase und der Hydrolyse des Phosphoenzyms beobachtet. Verwender wurden das native Substrat ATP und seine Analoga ADP, AMPPNP, 2'-deoxyATP, 3'-deoxyATP, ITP, AMP, Pyrophosphat, Ribosetriphosphat und TNP-AMP beobachtet. Diese Analoga waren an spezifischen funktionellen Gruppen des Substrats ATP modifiziert. Modifikation der 2'- und 3'-OH Gruppe des Ribosetriphosphats, der beta- und gamma-Phosphatgruppe und der Aminogruppe des Adenins reduzieren das Ausmaß an bindungsinduzierten Konformationsänderungen. Ein besonders starker Effekt wird für die 3'-OH Gruppe und die Aminogruppe des Adenins beobachtet. Dies zeigt die strukturelle Empfindlichkeit des Nukleotid-ATPase Komplexes auf einzelne Wechselwirkungen zwischen dem Nukleotid und der ATPase. Die Wechselwirkungen einer bestimmten Ligandengruppe mit der ATPase hängen von Wechselwirkungen anderer Ligandengruppen mit die ATPase ab. Die TNP-AMP Bindung verursacht teilweise gegenläufige und kleinere Konformationsänderungen verglichen mit ATP. Die Bindungweise von TNP-AMP ist unterschiedlich zu der von ATP, AMPPNP und anderen Tri- und Diphosphat Nucleotiden. Die Phosphorylierung der ATPase wurde mit ITP und 2'-deoxyATP beobachtet. Ca2E1P wurde in gleichem Ausmaß mit ITP und 2'-deoxyATP wie mit ATP akkumuliert, obwohl das Ausmaß der Konformationsänderungen bei Ca2E1P-Bildung geringer ist. Änderungen der 2'- und 3'-OH des Ribosetriphosphats und der Aminogruppe des Adenins beeinflussen die Reaktionsgeschwindigkeit der Phosphorylierung der ATPase. Es gibt keine direkte Verbindung zwischen dem Ausmaß der Konformationsänderung bei Nukleotid- Bindung und der Rate der Phosphorylierung. Das volle Ausmaß der ATP-induzierten Konformationsänderung ist nicht zwingend für die Phosphorylierung. Die Konformationen von Ca2E1N und Ca2E1P hängen vom Nukleotid ab. Dies weist darauf hin, dass die Struktur von ATPase Zuständen heterogener ist, als bisher erwartet. Die Aussagekraft und der Reichtum an Informationen in den Infrarotspektren zeigen, dass hiermit eine leistungsfähige Methode für die Untersuchung von Enzym-Substrat-Wechsel-Wirkungen und das räumliche Abtasten von Bindungstaschen zur Verfügung steht.
In the recent years, high-resolution conditions have been established in solid-state NMR by the combination of magic angle spinning, state-of-the-art r.f. pulse schemes and the introduction of ultra-high magnetic fields. Similar to what is now routine in solution-state NMR, this has opened the way for structure determination by HR-SSNMR methods. Complete structural or dynamical characterization of the biomolecule of interest is most easily achieved if multiple or even uniformly [13C, 15N]-labeled versions are studied. In a first step, experiments that allow the complete assignment of the 13C and 15N resonances have been recently designed. To date, nearly complete chemical shift assignments were reported for two well-ordered proteins, the ±-spectrin SH3 domain and the Crh protein. The SSNMR analysis of the later protein has been presented in Section 4.1. For SSNMR applications, not the molecular size or solubility, but the spectral resolution can be of crucial importance. Experimental parameters and sample inherent conditions such molecular disorder may reduce the overall spectral dispersion. In these circumstances, techniques that allow for spectral simplification without the need of elaborated biochemical procedures (of isotopelabeling) are of special importance. In Section 2, several spectral editing methods have been proposed. These methods not only select resonances due to changesin the physical and chemical environment of the nucleus but they can also directly probe molecular properties such as dynamics and conformational heterogeneity. Once the chemical shifts are available for the biomolecule of interest, methods that permit to obtain structural restraints can be applied. In the case of multiply isotope labeled proteins, such techniques can in principle result in multiple structural parameters. In Section 3.1, we have shown that, similar to solution-state NMR, secondary chemical shifts can be readily employed to study the local backbone conformation. Inaddition, distance constraints between protons may be encoded in high-resolution on rare spins like 13C and 15N and measured. Finally, carbon-carbon constraints may be probed by employing frequency selective r.f. pulse schemes. These dihedral and distance constraints may subsequently lead to the determination of protein secondary to tertiary structure from a single protein sample. In Section 4.2,we have shown that high-affinity ligand binding to membrane proteins can be investigated with solid-state NMR. Here, the neuropeptide neurotensin which binds to the Gprotein coupled receptor NTS1 in sub-nanomolar affinity was investigated.Except for the case of rhodopsin, there is currently no information on the high-resolution structure of any other GPCR or a corresponding high-affinity ligand.Our SSNMR results identify, for the first time, a distinct binding mode of neurotensin that could be of considerable relevance for further pharmacological studies. As exemplified in section 4.3, HR-SSNMR based structural studies can also assist in refining existing (X-ray or solution-state NMR) membrane-protein structures. The presented results provide, for the first time, direct experimental evidence for a double occupancy of the Q0 binding site in the ubiquinone-bc1 complex and may provide the basis for the complete 3D structural determination of the ubiquinone binding pocket. Advancements regarding sample preparation (for example, including modular labeling, in vitro expression and intein technology) and improvements in NMR hardware instrumentation could open up new areas of solid-state NMR research such as the investigation of large protein-protein complexes or the complete 3D characterization of larger membrane proteins. Solid-state NMR studies of multiply-labeled biomolecules will furthermore profit from improved procedures for calculating 3D structures, in particular in the presence of ambiguousor a limited number of structural constraints. Unlike X-ray crystallography, protein motion does not hinder solid-state NMR methods. In fact, complementary to solution-state NMR, it may provide a very efficient means to study protein folding, flexibility and function under biologically relevant conditions. Hand in hand with solution-state techniques and crystallographic methods, solid-state NMR could provide insight into protein function and the chemistry of life with unprecedented accuracy and flexibility.
Im ersten Teil dieser Arbeit sind Protein-Protein Docking-Studien dokumentiert. Bis heute konnten die meisten Protein-Komplex-Strukturen nicht experimentell aufgeklärt werden, so auch die beiden oben genannten Elektrontransfer-Komplexe. Nach einem erfolgreichen Test wurden verschiedene Cytochrom c Oxidase:Cytochrom c Paare mit der gleichen Methode gedockt: COX aus Paracoccus denitrificans mit Pferdeherz Cytochrom c und COX mit dem löslichen Fragment des membrangebundenen Cytochrom C552 (beide aus P. denitrificans). Im zweiten Teil dieser Arbeit wurde die diffusive Annäherung des Cytochrom c an die Cytochrom c Qxidase mit der Brownschen Dynamik Methode simuliert. Die Diffusionsbewegung eines Brownschen Teilchens in wässriger Lösung wird durch die Langevin-Gleichung bestimmt. Der auf dieser Gleichung fußende Ermak-McCammon-Algorithmus ist Grundlage der Simulationsmethode. Die so ermittelten Raten für COX und Pferdeherz, sowie für COX und Cytochrom C552, wurden dann mit experimentell gewonnenen Raten verglichen. Da die Elektrostatik für den Annäherungsprozeß dieser Proteine eine so gewichtige Rolle spielt, wirken sich Mutationen, die mit einer Ladungsänderung einhergehen, merklich aus. Dies ist vor allem dann der Fall, wenn sich die Mutation in der Nähe der Bindungsstelle befindet. Aus dem gleichen Grund ist die Assoziationsrate auch stark von der Ionenstärke der umgebenden Lösung abhängig. Steigt die Ionenkonzentration wird die elektrostatische Komplementarität der Bindingsstellen der beiden Makromoleküle stärker abgeschirmt, und die Rate sinkt. Diese beiden relativen Trends konnten durch die Simulationen gut reproduziert und bestätigt werden. Allerdings liegen die absoluten Resultate merklich über den experimentell gemessenen Raten. Es ist sehr gut möglich, daß post-diffusive Effekte, die nicht in einer Brownschen Dynamik Simulation von starren Körpern berücksichtigt werden können, die Raten erniedrigen. Um den Einfluß der Membranumgebung auf die Wechselwirkung des Elektrontransportsystems zu untersuchen. wurde eine DPPC Doppelschicht um die Oxidase modelliert und energieminimiert. Mit Poisson-Boltzmann Rechnungen wurde das elektrostatische Potential dieses Nanosystems untersucht und mit dem der einzelnen Oxidase verglichen. Durch einen modifizierten Set-up konnten dann auch für dieses Membransystem Brownsche Dynamik Simulationen durchgeführt werden. Der Vergleich mit den vorhergehenden Simulationen ohne Membran erbrachte bemerkenswerte Ergebnisse. Während die Assoziationsraten für Pferdeherz Cytochrom c durch den Membraneinfluß erniedrigt wurden, stiegen sie im Fall des physiologischen Transferpartners c552. Pferdeherz Cytochrom c weist eine positive Nettoladung und einen ausgeprägten bipolaren Charakter auf. Eine große Zahl positiv geladener Seitenketten befindet sich auf der gleichen Hemisphäre wie die Bindungsstelle. Obwohl die DPPC Lipidmoleküle neutral sind, zeigten die Elektrostatikrechnungen, daß die Membranoberfläche abstoßend auf positive Ladungen wirkt. Da sich nun die Bindungsstelle der Oxidase für Cytochrom c nur etwa 10 Å oberhalb der Membran befindet, verringert sich die Wahrscheinlichkeit der Assoziation.
The mechanism of peptide transport has been studied on two different ABC transporters of S. cerevisiae. Thereby, the aim of this PhD thesis was to characterise the transporter function on molecular level and shed light on the physiological role of these transporters. The ABC gene YLL048 encodes a novel intracellular transporter translocating peptides from the cytosol to the lumen of the ER. Deletion of the gene resulted in loss of peptide transport activity. The transport activity was fully restored after transformation of the deletion mutant by plasmid-encoded YLL048. Studying the substrate specificity using randomized peptide libraries it was demonstrated that peptides of the size from 6 to 56 amino acids are recognized. So far, no upper limit of the substrate size was obtained. Introduction of D-amino acids in various positions of a nonamer peptide did not impair transport activity. The physiological function of YLL048p is not well understood. The gene product is not essential for cell viability as the deletion mutant did not show any growth phenotype. To examine the possibility that YLL048 encoded protein is part of a quality control of yeast cells involved in the unfolded protein response (UPR), upregulation of YLL048 transcription by heat shock and stress conditions were investigated. We could not observe an influence of stress factors on YLL048 mRNA level. Upregulation of gene expression by the transcription factors Pdr1p and Pdr3p was excluded. The ABC transporter Mdl1p has been identified as peptide transporter of the inner mitochondrial membrane. This protein is required for the export of peptides with the size of 6 to 21 amino acids from the matrix into the intermembrane space. These peptides are generated by m-AAA proteases degrading non-assembled or missfolded membrane proteins. In order to understand the transport mechanism in detail, Mdl1p was expressed in S. cerevisiae and E. coli. Partially enriched protein was reconstituted into liposomes and was active in ATP binding. The association of the NBDs has been described as a central step of the ATPase cycle of ABC transporters, but it is still controversial how both motor domains cooperate and coordinate ATP hydrolysis. To address this question, the Mdl1p-NBD was overexpressed in E. coli and purified to homogeneity. The isolated NBD was active in ATP binding and hydrolysis with a turnover of 0.5 ATP per min and a Km value of 0.2 mM. Isolated NBDs did not show cooperativity in ATPase activity. However, the ATPase activity was observed to be non-linearly dependent on protein concentration suggesting the active form of this enzyme is not a monomer. Very importantly, for the first time an ATP-induced dimer was observed after trapping the NBD by ortho-vanadate or BeFx. The nucleotide composition of the trapped intermediate state was determined and two ADP molecules were simultaneously bound per dimer. An ATP-induced dimer of the ATPase inactive mutant (E559Q) was observed already in the absence of ATPase inhibitor. The E599Q dimer contained two ATP molecules in the absence of Mg2+ at 4°C. Prolonged incubation at 30°C in the presence of Mg2+ induced a stable dimer in which one ATP and ADP molecule were trapped at the same time. Based on these experiments, a new cycle for ATPase activity of ABC transporters was proposed. Binding of ATP to two NBD monomers induces dimerization. Both nucleotides are hydrolysed sequentially. During the hydrolysis cycle the nucleotides cannot be released from the dimer. After hydrolysis of two ATP molecules the domains dissociate and start a new cycle.